The Pharmaceutical Market: Vietnam

Date: January 31, 2013
Pages: 110
Price:
US$ 1,295.00
License [?]:
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P48E6C502E6EN
Leaflet:

Download PDF Leaflet

The Pharmaceutical Market: Vietnam
OVERVIEW OF THE PHARMACEUTICAL MARKET IN VIETNAM

Corruption will continue to affect Vietnam's pharmaceutical and healthcare business environment and potentially delay the introduction of universal healthcare coverage for its people. While corruption is a clear downside risk, we maintain that the sector still offers strong growth opportunities for foreign investors.

Headline Expenditure Projections

Pharmaceuticals: VND50,081bn (US$2.43bn) in 2011 to VND61,910bn (US$2.94bn) in 2012; +23.6% in local currency terms and +21.4% in US dollar terms.

Healthcare: VND157, 666bn (US$7.63bn) in 2011 to VND181,879bn (US$8.65bn) in 2012; +15.4% in local currency terms and +13.3% in US dollar terms.

Medical devices: VND15,137bn (US$733mn) in 2011 to VND17,029bn (US$810mn) in 2012; +12.5% in local currency terms and +10.5% in US dollar terms.

Competitive Landscape

The Competitive Landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
EXECUTIVE SUMMARY

SWOT ANALYSIS

    Vietnam Pharmaceutical And Healthcare Industry SWOT
    Vietnam Political SWOT
    Vietnam Economic SWOT
    Vietnam Business Environment SWOT

PHARMACEUTICAL RISK/REWARD RATINGS

    Table: Asia Pacific Pharmaceutical Risk/Reward Ratings, Q113
    Rewards
    Risks

VIETNAM – MARKET SUMMARY

REGULATORY REGIME

    Pharmaceutical Advertising
    Intellectual Property Environment
    IP Shortcomings
    Counterfeit Drugs
    Corruption
    Pricing Regime
    Price Spikes
    Reimbursement Regime
    Pricing And Reimbursement Developments

INDUSTRY TRENDS AND DEVELOPMENTS

    Epidemiology
    Communicable Diseases
    HIV/AIDS
    Non-Communicable Diseases
    Healthcare Financing
    Hospital Sector
    Private Healthcare Sector
    Healthcare Insurance
    Healthcare And Pharmaceutical Reform
    Foreign Partnerships
    Research & Development
    Biotechnology Sector
    Vaccines
    Clinical Trials
    Medical Device Market

INDUSTRY FORECAST SCENARIO

    Overall Market Forecast
    Table: Pharmaceutical Sales Indicators 2008-2016
    Healthcare Market Forecast
    Table: Healthcare Expenditure Indicators 2008-2016
    Table: Healthcare Governmental Indicators 2008-2016
      Table: Healthcare Private Indicators 2008-2016
      Key Growth Factors – Macroeconomic
      Table: Vietnam – Economic Activity
      Prescription Drug Market Forecast
      Table: Prescription Drug Sales Indicators 2008-2016
      Patented Drug Market Forecast
      Table: Patented Drug Market Indicators 2008-2016
      Generic Drug Market Forecast
      Table: Generic Drug Sales Indicators 2008-2016
      OTC Medicine Market Forecast
      Table: OTC Medicine Sales Indicators 2008-2016
      Pharmaceutical Trade Forecast
      Table: Exports and Imports Indicators 2008-2016
      Medical Device Market Forecast
      Table: Medical Devices Sales Indicators 2008-2016
      Other Healthcare Data Forecasts
      Key Risks To BMI’s Forecast Scenario

COMPETITIVE LANDSCAPE

      Pharmaceutical Industry
      Domestic Pharmaceutical Sector
      Foreign Pharmaceutical Sector
      Recent Pharmaceutical Industry News
      Traditional Medicines
      Pharmaceutical Distribution
      Pharmaceutical Retail Sector
      Table: Key Aspects Of Good Pharmacy Practice In Developing Countries

COMPANY PROFILES

  Local Companies
      Vietnam Pharmaceutical Corporation (Vinapharm)
      Vietnam OPV Pharmaceutical Co
      Vietnam Pharmaceutical Joint Stock Company (Ampharco)
      Vidipha Central Pharmaceutical Joint Stock Company
  Multinational Companies
      Pfizer
      Sanofi
      Novartis
      Merck & Co
      GlaxoSmithKline

VIETNAM DEMOGRAPHIC OUTLOOK

      Table: Vietnam’s Population By Age Group, 1990-2020 (‘000)
      Table: Vietnam’s Population By Age Group, 1990-2020 (% of total)
      Table: Vietnam’s Key Population Ratios, 1990-2020
      Table: Vietnam’s Rural And Urban Population, 1990-2020

GLOSSARY

BMI METHODOLOGY

      How We Generate Our Pharmaceutical Industry Forecasts
      Pharmaceuticals Risk/Reward Ratings Methodology
      Ratings Overview

TABLE: PHARMACEUTICAL BUSINESS ENVIRONMENT INDICATORS

WEIGHTING

TABLE: WEIGHTING OF COMPONENTS

SOURCES
Skip to top


The Pharmaceutical Market: Hungary US$ 1,295.00 Jan, 2013 · 95 pages
The Pharmaceutical Market: India US$ 1,295.00 Jan, 2013 · 117 pages
The Pharmaceutical Market: Indonesia US$ 1,295.00 Jan, 2013 · 117 pages

Ask Your Question

The Pharmaceutical Market: Vietnam
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: